New Treatments Hold Significant Promise, but are Marketing Teams Helping Life Sciences Companies Deliver on this Potential?

This whitepaper highlights the significance of understanding prescription rejection rates, particularly for specialty pharmacy medications, and the role of plan design and social determinants of health (SDOH) in determining eligibility and out-of-pocket costs for patients.  

Traditional analyses focusing solely on demographics like age and gender may overlook disparities in care delivery. Utilizing PurpleLab’s HealthNexus, we examined approximately 3.5 million Americans taking an anticoagulant drug. Results revealed disparities in prescription rejection rates, with Hispanic and African American patients being disproportionately affected, particularly those with lower incomes. These findings underscore the importance of considering SDOH factors in healthcare analytics to address disparities in care delivery effectively. 

Download our free whitepaper and delve deeper into prescription rejection rates beyond traditional demographic factors, and the importance of addressing inequalities to ensure equitable access to medication.